{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "AUD", "esgPopulated": false, "market": "au_market", "longName": "Chimeric Therapeutics Limited", "marketState": "PRE", "regularMarketPrice": 0.05, "messageBoardId": "finmb_689328948", "exchange": "ASX", "shortName": "CHIMERIC FPO", "exchangeTimezoneShortName": "AEST", "exchangeTimezoneName": "Australia/Sydney", "regularMarketChangePercent": 6.382984, "gmtOffSetMilliseconds": 36000000, "fiftyTwoWeekLowChange": 0.006000001, "fiftyTwoWeekLowChangePercent": 0.13636366, "fiftyTwoWeekRange": "0.044 - 0.15", "fiftyTwoWeekHighChange": -0.10000001, "fiftyTwoWeekHighChangePercent": -0.6666667, "fiftyTwoWeekLow": 0.044, "fiftyTwoWeekHigh": 0.15, "earningsTimestamp": 1677538172, "earningsTimestampStart": 1677538172, "earningsTimestampEnd": 1677538172, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.04, "epsForward": -0.06, "epsCurrentYear": -0.05, "firstTradeDateMilliseconds": 1610924400000, "priceHint": 4, "regularMarketChange": 0.0030000024, "regularMarketTime": 1683785404, "regularMarketDayHigh": 0.05, "regularMarketDayRange": "0.045 - 0.05", "regularMarketDayLow": 0.045, "regularMarketVolume": 870404, "regularMarketPreviousClose": 0.047, "bid": 0.048, "ask": 0.05, "fullExchangeName": "ASX", "financialCurrency": "AUD", "regularMarketOpen": 0.045, "averageDailyVolume3Month": 440894, "averageDailyVolume10Day": 675288, "priceEpsCurrentYear": -1.0, "sharesOutstanding": 437094016, "bookValue": 0.037, "fiftyDayAverage": 0.06484, "fiftyDayAverageChange": -0.014839996, "fiftyDayAverageChangePercent": -0.22887102, "twoHundredDayAverage": 0.084855, "twoHundredDayAverageChange": -0.034854997, "twoHundredDayAverageChangePercent": -0.4107595, "marketCap": 21854702, "forwardPE": -0.8333334, "priceToBook": 1.3513514, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "symbol": "CHM.AX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "62 Lygon Street", "address2": "Level 3", "city": "Carlton", "state": "VIC", "zip": "3053", "country": "Australia", "phone": "61 3 9824 5254", "fax": "61 3 9822 7735", "website": "https://www.chimerictherapeutics.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Chimeric Therapeutics Limited, a clinical stage cell therapy company, develops and commercializes a range of cell therapies in oncology in Australia. The company develops CHM 0201 (core NK platform) that is in phase I clinical trial for treating solid tumors and hematological malignancies; and CHM 1101 (CLTX CAR T), which is in phase I clinical trial for treating patients with MMP2+ recurrent or progressive glioblastoma. It is also developing CHM 0301 for blood cancers; CHM 1301 (CLTX CAR NK) and CHM 2301 (CDH17 CAR NK) for solid tumors; CHM 1101 (CLTX CAR T) for melanoma, colorectal, and prostate; and CHM 2101 (CDH17 CAR T) for neuroendocrine, colorectal, pancreatic, and gastric. The company was incorporated in 2020 and is based in Carlton, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Ms. Jennifer  Chow", "title": "CEO, MD & Director", "fiscalYear": 2022, "totalPay": {"raw": 1542846, "fmt": "1.54M", "longFmt": "1,542,846"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Eliot  Bourk", "title": "Chief Bus. Officer & Head of External Innovation", "fiscalYear": 2022, "totalPay": {"raw": 920726, "fmt": "920.73k", "longFmt": "920,726"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Li  Ren", "title": "VP of Technical Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Kelly R. Thornburg", "age": 59, "title": "VP & Head of Quality", "yearBorn": 1963, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jason B. Litten M.D.", "age": 48, "title": "Chief Medical Officer", "yearBorn": 1974, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Phillip  Hains B Bus, C.A., CA, M.B.A., MBA", "age": 61, "title": "Sec.", "yearBorn": 1961, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Nathan  Jong C.A.", "title": "Company Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}